Brief: Oragenics Inc Says On April 4, Co Concluded That Some Of Co's Consolidated Financial Statements Should No Longer Be Relied Upon
10/04/2023 21:50
April 10 (Reuters) - Oragenics Inc OGEN.A :
* ORAGENICS INC - ON APRIL 4, CO CONCLUDED THAT SOME OF CO'S
CONSOLIDATED FINANCIAL STATEMENTS SHOULD NO LONGER BE RELIED
UPON
* ORAGENICS -FINANCIAL STATEMENTS FOR INTERIM PERIODS ENDED
MARCH
31, 2022, ENDED JUNE 30, 2022, ENDED SEPT 30, 2022 SHOULD NO
LONGER BE RELIED UPON
Source text for Eikon: ID:
Further company coverage: OGEN.A
((Reuters.Brief@thomsonreuters.com;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing